Lemonade (LMND) just widened its footprint again. Renters in Alaska now have access to its app based insurance, while pet owners in Kentucky can buy tailored coverage and manage claims on their phones.
For investors watching Lemonade, the latest Alaska and Kentucky launches arrive after a stretch where the 30 day share price return is down 15.79% and the year to date share price return is lower by 41.28%, even though the 3 year total shareholder return is very large. This hints that recent weakness may reflect shifting sentiment around growth prospects and risk rather than a simple one way story.
Compare Lemonade's latest moves with a hand picked set of insurers and app based platforms in our list of solid balance sheet and fundamentals (25 results) to see how risk and resilience differ across the sector.
Lemonade’s share price has slid while analyst targets still sit materially higher, leaving a wide gap between where the market prices the story and where fair value estimates cluster. Which side is misreading this stock?
Most Popular Narrative: 9% Undervalued
Lemonade closed at $44.60 while the most followed narrative on the stock pegs fair value at $48.95. This points to a modest gap that hinges on how you view its underwriting progress and reinsurance reset.
Ignore the 79%. In-force premium, the measure of how much insurance Lemonade actually has on the books, grew 32.4% to $1.43 billion. Revenue grew 79% because ceded premiums fell roughly 49% as the company retained a larger share of its own risk. The company says as much in its letter.
See why 2 investors see Lemonade as 9% undervalued.
Result: Fair Value of $48.95 (UNDERVALUED)
Still, Lemonade’s higher risk retention and guidance that relies on future loss ratios and EBITDA targets could quickly unravel this narrative if those metrics slip.
Find out about the key risks to this Lemonade narrative.
Another View On Lemonade’s Valuation
The story looks very different once you swap narrative fair value for the hard numbers on Lemonade’s P/S ratio. The stock trades around 3.5x sales while the US Insurance industry averages 1.1x and close peers sit near 1.9x. The fair ratio sits at 1.8x, which points to a meaningful valuation gap that could either compress or hold if the growth story stays intact. Which side of that spread do you want to be on as sentiment shifts again?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed views around Lemonade’s story are clear. Move quickly, test the numbers yourself and balance both sides of the argument with 2 key rewards and 2 important warning signs.
Looking for more investment ideas beyond Lemonade?
If Lemonade has your attention, do not stop here. Fresh ideas across sectors can sharpen your portfolio and reveal opportunities you would otherwise miss.
- Pinpoint potential value gaps by scanning 31 high quality undervalued stocks that combine solid fundamentals with more appealing entry points.
- Steady your portfolio by reviewing 32 resilient stocks with low risk scores that carry lower risk scores while still offering meaningful exposure to the market.
- Get ahead of the crowd by tracking 17 high quality undiscovered gems before broader attention and capital start to follow.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com